Sociodemographic profile and clinical presentation of young children unintentionally exposed to marijuana: A single site retrospective cohort.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9208821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0391 (Electronic) Linking ISSN: 10550496 NLM ISO Abbreviation: Am J Addict Subsets: MEDLINE

Publication: Oxford : Wiley-Blackwell
Original Publication: Washington, DC : American Psychiatric Press, c1992-

Medical Marijuana*/therapeutic use ; Emergency Service, Hospital*/statistics & numerical data; Humans ; Female ; Male ; Retrospective Studies ; Child, Preschool ; Ohio/epidemiology ; Infant ; Child ; Infant, Newborn ; Sociodemographic Factors ; United States/epidemiology ; Socioeconomic Factors

Background and Objectives: Legalization of medical marijuana has increased unintentional exposure to marijuana in young children. We aim to explore the sociodemographic disadvantage profile, prevalence, and clinical presentation of children diagnosed with unintentional exposure to marijuana.
Methods: We conducted a retrospective chart abstraction of 121 children (aged 0-6) seen at the Emergency Department (ED) at a single tertiary hospital center in Dayton, Ohio between January 01, 2010 and January 09, 2022.
Results: Majority were female (62.8%), white (50.4%), and with Medicaid as their primary insurance (84.3%). The median age at exposure was 1.8 years. There was a 14-fold increase in unintentional marijuana cases pre-2017 (7 cases) versus post-2017 (114 cases), the year of legalization of medical marijuana in the state of Ohio. Majority of the patients were using public assistance (66.4%). 26.7% of the cases had a prior social work consultation and 38.1% had a prior children services consultation. 51.3% of the children had a social disadvantage index score of 3 or greater (range 0-5) with higher scores indicating greater disadvantage.
Discussion and Conclusions: The number of patients presenting to the ED at the hospital has increased 14-fold since the legalization of medical marijuana in Ohio. Half of the children displayed a higher sociodemographic disadvantage index score.
Scientific Significance: Our study is the first study investigating the sociodemographic profile of children exposed to marijuana. The findings of this study may be utilized to inform policy for safely dispensing recreational and medicinal marijuana products and focus the efforts on families with sociodemographic disadvantage.
(© 2024 The Authors. The American Journal on Addictions published by Wiley Periodicals LLC on behalf of The American Academy of Addiction Psychiatry (AAAP).)

United Nation Office on Drugs and Crime. Drug market trends–Cannabis opioids. Booklet 3: drug use and health consequences. World Drug Report. Accessed June 19, 2023. 2022. https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_3.pdf.
Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20‐07‐01‐001, NSDUH Series H‐55). Accessed June 19, 2023. 2022. https://www.samhsa.gov/data/report/2019-nsduh-annual-national-report.
Schuermeyer J, Salomonsen‐Sautel S, Price RK, et al. Temporal trends in marijuana attitudes, availability and use in Colorado compared to non‐medical marijuana states: 2003‐11. Drug Alcohol Depend. 2014;140:145‐155. doi:10.1016/j.drugalcdep.2014.04.016.
Wang GS, Le Lait MC, Deakyne SJ, Bronstein AC, Bajaj L, Roosevelt G. Unintentional pediatric exposures to marijuana in Colorado, 2009–2015. JAMA Pediatr. 2016;170(9):e160971. doi:10.1001/jamapediatrics.2016.0971.
Dean D, Passalacqua KD, Oh SM, Aaron C, Van Harn MG, King A. Pediatric cannabis single‐substance exposures reported to the Michigan Poison Center from 2008–2019 after medical marijuana legalization. J Emerg Med. 2021;60(6):701‐708. doi:10.1016/j.jemermed.2020.12.028.
Tweet MS, Nemanich A, Wahl M. Pediatric edible cannabis exposures and acute toxicity: 2017–2021. Pediatrics. 2023;151(2):e2022057761. doi:10.1542/peds.2022-057761.
Kim HS, Monte AA. Colorado cannabis legalization and its effect on emergency care. Ann Emerg Med. 2016;68(1):71‐75. doi:10.1016/j.annemergmed.2016.01.004.
Whitehill JM, Harrington C, Lang CJ, Chary M, Bhutta WA, Burns MM. Incidence of pediatric cannabis exposure among children and teenagers aged 0 to 19 years before and after medical marijuana legalization in Massachusetts. JAMA Netw Open. 2019;2(8):e199456. doi:10.1001/jamanetworkopen.2019.9456.
Wang GS, Roosevelt G, Heard K. Pediatric marijuana exposures in a medical marijuana state. JAMA Pediatr. 2013;167(7):630‐633. doi:10.1001/jamapediatrics.2013.140.
Stoner MJ, Dietrich A, Lam SHF, Wall JJ, Sulton C, Rose E. Marijuana use in children: an update focusing on pediatric tetrahydrocannabinol and cannabidiol use. J Am Coll Emerg Physicians Open. 2022;3(4):e12770. doi:10.1002/emp2.12770.
Wang GS. Cannabis (marijuana): acute intoxication. UpToDate. Accessed June 19, 2023. May 22, 2023. https://www.uptodate.com/contents/cannabis-marijuana-acute-intoxication.
Murray D, Olson J, Lopez AS. When the grass isn't greener: a case series of young children with accidental marijuana ingestion. Can J Emerg Manag. 2016;18(6):480‐483. doi:10.1017/cem.2015.44.
Richards JR, Smith NE, Moulin AK. Unintentional cannabis ingestion in children: a systematic review. J Pediatr. 2017;190:142‐152. doi:10.1016/j.jpeds.2017.07.005.
Kam AJ. Grandma's brownies are not what they used to be: acute intoxication from cannabis ingestion. Paediatr Child Health. 2020;25(suppl 1):S3‐S4. doi:10.1093/pch/pxaa014.
Coret A, Rowan‐Legg A. Unintentional cannabis exposures in children pre‐ and post‐legalization: a retrospective review from a Canadian paediatric hospital. Paediatr Child Health. 2022;27(5):265‐271. doi:10.1093/pch/pxab090.
Tobin T, Xie J, George K. Unintentional pediatric ingestion of cannabis—addressing a growing public health risk. JAMA Pediatr. 2023;177:993. doi:10.1001/jamapediatrics.2023.2652.
Hasin DS, Shmulewitz D, Sarvet AL. Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings. Am J Drug Alcohol Abuse. 2019;45(6):623‐643. doi:10.1080/00952990.2019.1569668.
Braveman P, Barclay C. Health disparities beginning in childhood: a life‐course perspective. Pediatrics. 2009;124(suppl 3):S163‐S175. doi:10.1542/peds.2009-1100D.
Amato PR. Does social and economic disadvantage moderate the effects of relationship education on unwed couples? An analysis of data from the 15‐month Building Strong Families evaluation. Fam Relat. 2014;63(3):343‐355. doi:10.1111/fare.12069.
Tonini E, Quidé Y, Whitford TJ, Green MJ. Cumulative sociodemographic disadvantage partially mediates associations between childhood trauma and schizotypy. Br J Clin Psychol. 2022;61:444‐464. doi:10.1111/bjc.12349.
Oyegbile‐Chidi T, Temitayo, Harvey D, Jones J, et al. Impact of sociodemographic disadvantage on neurobehavioral outcomes in children with newly diagnosed seizures and their unaffected siblings over 36 months. Epilepsia. 2023;64(8):2172‐2185. doi:10.1111/epi.17672.
Knopp K, Stanley SM, Rhoades GK. Moderated mediation in relationship education: communication, commitment, and sociodemographic disadvantage. J Fam Psychol. 2022;36:1084‐1094. doi:10.1037/fam0000958.
Berkowitz SA, Traore CY, Singer DE, Atlas SJ. Evaluating area‐based socioeconomic status indicators for monitoring disparities within health care systems: results from a primary care network. Health Serv Res. 2015;50(2):398‐417. doi:10.1111/1475-6773.12229.
US Census. American Community Survey's 2021 5 year estimate. Accessed September 27, 2023. 2023. https://www.incomebyzipcode.com/ohio/.
Leubitz A, Spiller HA, Jolliff H, Casavant M. Prevalence and clinical characteristics of unintentional ingestion of marijuana in children younger than 6 years in states with and without legalized marijuana laws. Pediatr Emerg Care. 2021;37(12):e969‐e973. doi:10.1097/PEC.0000000000001841.
Ohio Department of Medicaid. Who qualifies. Accessed May 31, 2023. 2023. https://medicaid.ohio.gov/families-and-individuals/coverage/who-qualifies/who-qualifies.
Shippee TP, Schafer MH, Ferraro KF. Beyond the barriers: racial discrimination and use of complementary and alternative medicine among Black Americans. Soc Sci Med. 2012;74(8):1155‐1162. doi:10.1016/j.socscimed.2012.01.003.
DeLisi M, Drury AJ, Elbert MJ. Parent exposure to drugs: a “new” adverse childhood experience with devastating behavioral consequences. J Drug Issues. 2018;49(1):91‐105. doi:10.1177/0022042618805738.
Way I, Chung S, Jonson‐Reid M, Drake B. Maltreatment perpetrators: a 54‐month analysis of recidivism. Child Abuse Negl. 2001;25(8):1093‐1108. doi:10.1016/s0145-2134(01)00258-7.
Drake B, Pandey S. Understanding the relationship between neighborhood poverty and specific types of child maltreatment. Child Abuse Negl. 1996;20(11):1003‐1018. doi:10.1016/0145-2134(96)00091-9.
Bostwick JM. Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clin Proc. 2012;87(2):172‐186. doi:10.1016/j.mayocp.2011.10.003.
Volkow ND, Glissmeyer EW, Nelson DS, et al. Adverse health effects of marijuana use. N Engl J Med. 2014;370:2219‐2227. doi:10.1056/NEJMra1402309.
Krist AH, Davidson KW, Mangione CM, et al. Screening for unhealthy drug use: US Preventive Services Task Force recommendation statement. JAMA. 2020;323(22):2301‐2309. doi:10.1001/jama.2020.8020.
Madras BK, Han B, Compton WM, Jones CM, Lopez EI, McCance‐Katz EF. Associations of parental marijuana use with offspring marijuana, tobacco, and alcohol use and opioid misuse. JAMA Netw Open. 2019;2(11):e1916015. doi:10.1001/jamanetworkopen.2019.16015.
Hammig B, Jones C, Haldeman S. Pediatric poisonings associated with ingestion of marijuana products. J Emerg Med. 2023;64(2):181‐185. doi:10.1016/j.jemermed.2022.12.025.

0 (Medical Marijuana)

Date Created: 20240515 Date Completed: 20241024 Latest Revision: 20241024

20250114

10.1111/ajad.13617

38745358